Key insights
- Celestica (CLS) reported strong Q1 results and raised its 2026 revenue outlook significantly, driven by AI capacity buildout. Despite this positive news, the stock dropped as the market questions the durability of AI demand and the company's ability to execute its ambitious growth plans. Increased capital expenditure to support this growth adds to the pressure. Overall, the report strengthens the company's story but raises the bar for future performance.
Looking through CLS's Q1 numbers today and one thing really stood out.
The Q1 beat was great (revenue up 53%, margins hit 8%), but the part that changes the whole read is their new 2026 revenue outlook: $19.0 billion.
Just 90 days ago, they raised the target to $17.0B, which already felt aggressive given 2025 revenue was $12.39B. Now they're saying $19B. That means they expect to add ~$6.6 billion in revenue this year. In plain English, they're guiding to add more revenue in a single year than the entire company generated in 2021.
That's not a normal EMS growth story. It's a massive AI capacity buildout.
But the stock still dropped ~7.6% after the bell. Why? Because the bar has totally shifted. At ~$390/share (around 38x 2026 adjusted earnings), the market isn't just asking if AI demand is real anymore. It's asking if this demand is durable enough to justify building the next version of the company around it.
Management threw in some strong language about 2027 visibility and a new hyperscaler program, but they're still a hardware manufacturer at the end of the day. They have to add capacity and spend real capital (capex rose to $229.5M from $36.7M last year) before all that future revenue actually shows up.
Basically, the quarter made Celestica's story stronger, but it also made the burden of proof way heavier.